You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 22, 2026

Pantop - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

Drug Prices for pantop

See drug prices for pantop

Generic filers with tentative approvals for PANTOP

Applicant	Application No.	Strength	Dosage Form
⤷ Get Started Free	⤷ Get Started Free	40MG	INJECTABLE; INJECTION
⤷ Get Started Free	⤷ Get Started Free	EQ 40MG BASE/VIAL	POWDER;INTRAVENOUS

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

US Patents and Regulatory Information for pantop

+ Get email alerts for changes to this table

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal Pharms	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	205119-001	Jan 26, 2016	AB	RX	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Graviti Pharms	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	219087-001	Jan 16, 2025	AB	RX	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Cipla	PANTOPRAZOLE SODIUM	pantoprazole sodium	FOR SUSPENSION, DELAYED RELEASE;ORAL	217458-001	Mar 31, 2025	AB	RX	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Mylan Pharms Inc	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	090970-001	Jan 19, 2011	AB	RX	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Rubicon Research	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	090807-002	May 2, 2012	AB	RX	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Teva	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	077056-002	Aug 2, 2007		DISCN	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.